A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis

Author： Rudolph M.W. Klein S. Beckert T.E. Petereit H.-U. Dressman J.B.

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.51, Iss.3, 2001-05, pp. : 183-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current therapy of ulcerative colitis in children

By Bremner Alan Ronald Griffiths David Mervyn Beattie Robert Mark

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 37-53

Informa Healthcare

Access to resources Recommend Favorite

Immunosuppressive and biologic therapy for ulcerative colitis

By Ardizzone Sandro Cassinotti Andrea de Franchis Roberto

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 449-467

Informa Healthcare

Access to resources Recommend Favorite

Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride - P(CBFAS)

By Cai Q.X. Zhu K.J. Chen D. Gao L.P.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 2, 2003-03 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1396-1405

Bentham Science Publishers

Access to resources Recommend Favorite

Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease

By Bautzováá Tereza Rabišškováá Miloslava Lamprecht Alf

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 9, 2011-09 ,pp. : 1100-1109

Informa Healthcare

Access to resources Recommend Favorite